At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,372 enrolled
Drug / intervention
botulinum toxin type Aother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
MDs on Botox Utility (MOBILITY)
In Brief
An observational study evaluating botulinum toxin type A for Blepharospasm and 3 related conditions. Completed, enrolled 1,372 participants across 1 site.
Detailed Summary
The MOBILITY Project is a prospective, non-randomized, observational, multi-centre evaluation of Health Utility via the SF-12® Health Survey Scores and the SF-6D in patients receiving BOTOX® for therapeutic use.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBlepharospasm, Torticollis, Strabismus, Muscle Spasticity
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2007
First PostedSep 2007
Primary CompletionSep 2013
TodayJul 2026
First PostedSep 27, 2007
Enrollment StartSep 1, 2007
Primary CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 6 yearsPosted 18.8 years ago
Interventions
botulinum toxin type Aother
There will be no protocol-mandated intervention with regard to physician treatment choice or management of patient condition once the patient is enrolled in the project.